 |
PDBsum entry 2jy8
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Protein binding
|
PDB id
|
|
|
|
2jy8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Protein binding
|
 |
|
Title:
|
 |
Nmr structure of the ubiquitin associated (uba) domain of p62 (sqstm1) in complex with ubiquitin. Rdc refined
|
|
Structure:
|
 |
Ubiquitin-binding protein p62. Chain: a. Fragment: uba domain. Synonym: sequestosome-1, phosphotyrosine-independent ligand for the lck sh2 domain of 62 kda, ebi3-associated protein of 60 kda, p60, ebiap. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: sqstm1, orca, osil. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Expression_system_variant: (de3).
|
|
NMR struc:
|
 |
21 models
|
 |
|
Authors:
|
 |
J.E.Long,R.Layfield,M.S.Searle
|
Key ref:
|
 |
J.Long
et al.
(2008).
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch.
J Biol Chem,
283,
5427-5440.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
07-Dec-07
|
Release date:
|
18-Dec-07
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q13501
(SQSTM_HUMAN) -
Sequestosome-1 from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
440 a.a.
52 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
283:5427-5440
(2008)
|
|
PubMed id:
|
|
|
|
|
| |
|
Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch.
|
|
J.Long,
T.R.Gallagher,
J.R.Cavey,
P.W.Sheppard,
S.H.Ralston,
R.Layfield,
M.S.Searle.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The p62 protein functions as a scaffold in signaling pathways that lead to
activation of NF-kappaB and is an important regulator of osteoclastogenesis.
Mutations affecting the receptor activator of NF-kappaB signaling axis can
result in human skeletal disorders, including those identified in the C-terminal
ubiquitin-associated (UBA) domain of p62 in patients with Paget disease of bone.
These observations suggest that the disease may involve a common mechanism
related to alterations in the ubiquitin-binding properties of p62. The
structural basis for ubiquitin recognition by the UBA domain of p62 has been
investigated using NMR and reveals a novel binding mechanism involving a slow
exchange structural reorganization of the UBA domain to a "bound" non-canonical
UBA conformation that is not significantly populated in the absence of
ubiquitin. The repacking of the three-helix bundle generates a binding surface
localized around the conserved Xaa-Gly-Phe-Xaa loop that appears to optimize
both hydrophobic and electrostatic surface complementarity with ubiquitin. NMR
titration analysis shows that the p62-UBA binds to Lys 48-linked di-ubiquitin
with approximately 4-fold lower affinity than to mono-ubiquitin, suggesting
preferential binding of the p62-UBA to single ubiquitin units, consistent with
the apparent in vivo preference of the p62 protein for Lys 63-linked
polyubiquitin chains (which adopt a more open and extended structure). The
conformational switch observed on binding may represent a novel mechanism that
underlies specificity in regulating signalinduced protein recognition events.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIGURE 1. Sequence and structure of the p62 protein and its
UBA domain. Schematic representation of the p62 protein and its
domain structure is shown (A). The sequence of the C-terminal
UBA domain is shown expanded with the numbering from the
full-length protein shown (residues 387–436). The position of
the conserved Met-Gly-Phe-Ser loop is underlined; Gly^410 and
Gly^411 correspond to the double glycine insertion (B). The
secondary structure content of the UBA domain identified in the
unbound form by NMR is shown in C. NMR structure of the p62-UBA
domain shows the position of mutated residues associated with
Paget disease of bone (D), and a ribbon structure of the UBA
domain shows the packing of core hydrophobic residues Met^401,
Leu^417, Ala^427, and Ile^431 (E).
|
 |
Figure 3.
FIGURE 3. Structural analysis of the p62 UBA domain and the
binding surfaces of the UBA and mUb. Chemical shift
perturbations are mapped to the surface of Ub on a linear scale
of white to red (largest) (A), as described by the data in Fig.
2B. B, surface representation of the structure of the p62-UBA
domain in the Ub-bound state showing the surface charge
distribution (acidic, red, and basic, blue) and hydrophobicity
(white). The structure is viewed toward the Met-Gly-Phe-Ser loop
region. C, identical orientation and representation of the UBA
domain of p62 showing secondary fast exchange chemical shift
perturbations (red) indicative of binding interactions with mUb.
These binding perturbations correlate well with the hydrophobic
surface shown in B, comprising residues within loop 1 and the C
terminus of helix 3. Ribbon diagram shows NMR structures of the
unbound UBA domain (D) and the bound form in the presence of 6
eq of mUb (E). The structural statistics are shown in Table 1.
In the unbound state the environment of the side chain of
Gln^400 is defined by NOEs with residues Phe^406, Ile^424, and
Leu^428 (F); in contrast, the repacking of the helices in the
bound state shows that Gln^400 is close in space to Trp^412,
Leu^416, and Leu^417 (G). In this conformation the side chains
of Phe^406, Ile^424, and Leu^428 are more remote from Gln^400. A
schematic representation of the two structures is shown to
illustrate more clearly the structural reorganization and
repacking of the three helices that occurs (H). The cylindrical
arrows represent the orientation and polarity of the helices. H,
free (blue) and bound (red) structures are shown with a common
alignment of helices 1 and 2. These structures are superimposed
in I, showing the different positions and orientations of helix
3 in the two forms.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2008,
283,
5427-5440)
copyright 2008.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Heinen,
K.Acs,
D.Hoogstraten,
and
N.P.Dantuma
(2011).
C-terminal UBA domains protect ubiquitin receptors by preventing initiation of protein degradation.
|
| |
Nat Commun,
2,
191.
|
 |
|
|
|
|
 |
B.E.Riley,
S.E.Kaiser,
T.A.Shaler,
A.C.Ng,
T.Hara,
M.S.Hipp,
K.Lage,
R.J.Xavier,
K.Y.Ryu,
K.Taguchi,
M.Yamamoto,
K.Tanaka,
N.Mizushima,
M.Komatsu,
and
R.R.Kopito
(2010).
Ubiquitin accumulation in autophagy-deficient mice is dependent on the Nrf2-mediated stress response pathway: a potential role for protein aggregation in autophagic substrate selection.
|
| |
J Cell Biol,
191,
537-552.
|
 |
|
|
|
|
 |
F.Wu-Baer,
T.Ludwig,
and
R.Baer
(2010).
The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
|
| |
Mol Cell Biol,
30,
2787-2798.
|
 |
|
|
|
|
 |
M.S.Willis,
W.H.Townley-Tilson,
E.Y.Kang,
J.W.Homeister,
and
C.Patterson
(2010).
Sent to destroy: the ubiquitin proteasome system regulates cell signaling and protein quality control in cardiovascular development and disease.
|
| |
Circ Res,
106,
463-478.
|
 |
|
|
|
|
 |
S.Geisler,
K.M.Holmström,
D.Skujat,
F.C.Fiesel,
O.C.Rothfuss,
P.J.Kahle,
and
W.Springer
(2010).
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1.
|
| |
Nat Cell Biol,
12,
119-131.
|
 |
|
|
|
|
 |
J.Song,
J.K.Park,
J.J.Lee,
Y.S.Choi,
K.S.Ryu,
J.H.Kim,
E.Kim,
K.J.Lee,
Y.H.Jeon,
and
E.E.Kim
(2009).
Structure and interaction of ubiquitin-associated domain of human Fas-associated factor 1.
|
| |
Protein Sci,
18,
2265-2276.
|
 |
|
|
|
|
 |
R.Schmucki,
S.Yokoyama,
and
P.Güntert
(2009).
Automated assignment of NMR chemical shifts using peak-particle dynamics simulation with the DYNASSIGN algorithm.
|
| |
J Biomol NMR,
43,
97.
|
 |
|
|
|
|
 |
V.Kirkin,
D.G.McEwan,
I.Novak,
and
I.Dikic
(2009).
A role for ubiquitin in selective autophagy.
|
| |
Mol Cell,
34,
259-269.
|
 |
|
|
|
|
 |
Y.Yoshikawa,
M.Ogawa,
T.Hain,
M.Yoshida,
M.Fukumatsu,
M.Kim,
H.Mimuro,
I.Nakagawa,
T.Yanagawa,
T.Ishii,
A.Kakizuka,
E.Sztul,
T.Chakraborty,
and
C.Sasakawa
(2009).
Listeria monocytogenes ActA-mediated escape from autophagic recognition.
|
| |
Nat Cell Biol,
11,
1233-1240.
|
 |
|
|
|
|
 |
M.Seton
(2008).
Paget's disease: epidemiology and pathophysiology.
|
| |
Curr Osteoporos Rep,
6,
125-129.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |